Article
Bispecific antibodies targeting cancer cells
1 Aug 2002
Abstract excerpt
In recent years, antibody therapy has become a new treatment modality for tumour patients, although the majority of responses are only partial and not long lasting. Based on evidence that effector-cell-mediated mechanisms significantly contribute to antibody efficacy in vivo, several approaches are currently pursued to improve the interaction between Fc receptor-expressing effector cells and tumour target...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.